Last reviewed 2026-04-23 · How we verify

DSXS topical product

DSXS topical product is a corticosteroid that reduces inflammation and itching by suppressing the immune system.

DSXS topical product is a corticosteroid that reduces inflammation and itching by suppressing the immune system. Used for Seborrheic dermatitis, Psoriasis.

At a glance

Mechanism of action

Corticosteroids like DSXS work by inhibiting the production of inflammatory mediators, such as prostaglandins and leukotrienes, which contribute to the symptoms of inflammation and itching. By suppressing the immune system, DSXS reduces the body's natural response to allergens and irritants, providing relief from symptoms.

Approved indications

• Seborrheic dermatitis
• Psoriasis

Common side effects

• Skin irritation
• Allergic contact dermatitis
• Hypersensitivity reactions

Key clinical trials

• Clinical Study to Evaluate the Efficacy and Safety of DSXS in Patients With Mild to Moderate Plaque Psoriasis (PHASE3)
• Safety Study in Patients With Scalp Psoriasis Suppression Following Maximal Use Treatment With Topical Product (PHASE2)
• Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis (PHASE3)
• An Open Label, Safety Study to Assess the Potential for Adrenal Suppression. (PHASE2)
• Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Atopic Dermatitis (PHASE2)
• Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis (PHASE3)
• Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis (PHASE3)
• Safety Study to Assess the Potential for Adrenal Suppression Following Maximal Use Treatment With DSXS (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.